Gene expression-based, individualized diagnostic GC/ABC prediction for relapse/refractory diffuse large B cell lymphoma (DLBCL)

ABSTRACT: Individualized diagnosis prediction classifiers were successfully constructed through expression profiling of a total of 8,644 genes in 49 patients with relapse/refractory diffuse large B cell lymphoma, prospectively treated in a randomized trial. keyword(s): Diagnosis prediction All lymphoma cases were predicted as belonging either to germical center B-cell like DLBCL or activated B cell like DLBCL based on the expression of a set of 54 genes (140 probes).

ORGANISM(S): Homo sapiens

SUBMITTER: Edouard Hirchaud 

PROVIDER: E-GEOD-26812 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress